Biotech Unveiling Next-Gen Sequencing’s Impact on Clinical Practice and Global Markets April 22, 2024
Biotech IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancer April 22, 2024
Biotech Hyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat triple-negative breast cancer April 22, 2024
Biotech Chiesi Group’s 2023 Revenue Surpasses €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices April 22, 2024
Biotech Prescient Healthcare Group Announces the Appointment of Two New Members to Its Board of Directors April 22, 2024
Biotech Stacey Lasser of Mednet to Present at the 2nd Annual Clinical Outsourcing Group New England Conference in Boston April 20, 2024
Biotech ARTHEx Biotech Announces Oral Presentation on ATX-01 at the Oligonucleotide & Peptide Therapeutics (TIDES) Conference 2024 April 19, 2024